LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -20.52%547.14M | -25.39%93.62M | -13.02%129.14M | -13.27%167.94M | -29.15%156.44M | 139.19%688.4M | -30.90%125.48M | 62.51%148.46M | 459.22%193.63M | 1,216.33%220.82M |
Net income from continuing operations | -25.11%416.72M | -72.88%35.82M | -6.38%91.69M | -5.88%144.72M | -16.30%144.49M | 43.45%556.45M | -39.52%132.11M | -13.66%97.94M | 122.73%153.76M | 1,427.84%172.63M |
Operating gains losses | -20.26%-41.6M | 99.39%-154K | -1,069.29%-13.54M | -107,223.08%-27.85M | 99.52%-51K | -56.32%-34.59M | -138.82%-25.29M | 897.86%1.4M | 100.86%26K | -23.74%-10.73M |
Depreciation and amortization | 15.81%149.44M | 17.17%39.47M | 17.81%39.3M | 12.55%36.52M | 15.58%34.15M | 16.89%129.04M | 18.58%33.68M | 20.32%33.36M | 19.04%32.45M | 9.44%29.55M |
Other non cash items | -123.98%-57.42M | -160.75%-13.49M | -241.00%-22.02M | -349.72%-12.93M | 19.34%-8.98M | 22.16%-25.64M | 6.06%-5.18M | -3.36%-6.46M | 55.57%-2.88M | 24.33%-11.13M |
Change In working capital | 14.03%62.29M | 260.68%20.02M | 56.55%31.6M | 207.60%25.54M | -138.51%-14.86M | 132.72%54.63M | 76.18%-12.46M | 144.44%20.18M | 115.43%8.3M | 349.71%38.6M |
-Change in receivables | 44.67%61.64M | 120.38%5.57M | 50.44%31.99M | 186.36%19.88M | -89.92%4.21M | 123.33%42.61M | 54.16%-27.34M | 144.08%21.26M | 111.30%6.94M | 412.26%41.75M |
-Change in payables and accrued expense | -110.79%-942K | ---- | ---- | ---- | ---- | -33.34%8.73M | ---- | ---- | ---- | ---- |
-Change in other working capital | -51.57%1.59M | 150.36%15.39M | -256.78%-9.71M | 398.50%14.99M | -505.91%-19.07M | 25.83%3.28M | 206.63%6.15M | ---2.72M | --3.01M | ---3.15M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -20.52%547.14M | -25.39%93.62M | -13.02%129.14M | -13.27%167.94M | -29.15%156.44M | 139.19%688.4M | -30.90%125.48M | 62.51%148.46M | 459.22%193.63M | 1,216.33%220.82M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -24.75%-155.02M | -139.60%-17.93M | -204.20%-40.67M | 60.76%-53.51M | 40.60%-42.9M | -390.35%-124.27M | 590.72%45.28M | 134.69%39.03M | -176.10%-136.36M | -393.04%-72.23M |
Capital expenditure reported | -35.60%-280.18M | -368.80%-62.71M | -199.91%-13.79M | -45.42%-176.56M | 59.67%-27.12M | -77.08%-206.63M | 52.91%-13.38M | 86.46%-4.6M | -662.09%-121.41M | -75.22%-67.25M |
Net PPE purchase and sale | 1.35%66.9M | -110.92%-5.02M | 70,311.76%23.87M | 97,946.94%48.04M | --0 | -33.44%66M | 133.56%45.97M | 75.36%-34K | -99.91%49K | -17.46%20.02M |
Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net investment purchase and sale | 256.14%58.27M | 292.28%49.8M | -216.22%-50.75M | 600.00%75M | 36.87%-15.78M | 120.81%16.36M | 2,639.00%12.7M | 156.49%43.67M | -4,723.15%-15M | -4,643.83%-25M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -24.75%-155.02M | -139.60%-17.93M | -204.20%-40.67M | 60.76%-53.51M | 40.60%-42.9M | -390.35%-124.27M | 590.72%45.28M | 134.69%39.03M | -176.10%-136.36M | -393.04%-72.23M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 46.94%-361.38M | 88.25%-21.49M | 1.97%-161.3M | 32.83%-77.79M | 53.72%-100.8M | -266.61%-681.12M | -75.69%-182.98M | -369.55%-164.54M | -100.72%-115.8M | -2,061.91%-217.79M |
Net issuance payments of debt | 88.76%-39.15M | 131.13%37.54M | 31.89%-62.51M | 189.42%17.51M | 72.77%-31.68M | -291.68%-348.3M | -161.65%-120.6M | -1,169.36%-91.78M | 61.35%-19.58M | -873.01%-116.35M |
Net common stock issuance | -79.24%-25M | --0 | ---25M | ---- | ---- | 30.32%-13.95M | --0 | --0 | ---- | ---- |
Cash dividends paid | 7.70%-284.42M | 3.47%-59.03M | -6.27%-73.79M | -9.69%-86.93M | 34.23%-64.66M | -341.22%-308.15M | -11.17%-61.15M | -1,079.08%-69.44M | -1,229.51%-79.25M | -3,199.09%-98.31M |
Net other financing activities | -19.54%-12.81M | --0 | --0 | -176.70%-8.36M | -42.10%-4.45M | -53.00%-10.72M | 59.61%-1.23M | -74.72%-3.33M | -180.07%-3.02M | -222.99%-3.13M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 46.94%-361.38M | 88.25%-21.49M | 1.97%-161.3M | 32.83%-77.79M | 53.72%-100.8M | -266.61%-681.12M | -75.69%-182.98M | -369.55%-164.54M | -100.72%-115.8M | -2,061.91%-217.79M |
Net cash flow | ||||||||||
Beginning cash position | -47.99%126.76M | -25.66%103.31M | 51.82%176.14M | -20.08%139.5M | -47.99%126.76M | 146.37%243.74M | -20.82%138.98M | -49.93%116.02M | 130.87%174.55M | 146.37%243.74M |
Current changes in cash | 126.28%30.75M | 543.66%54.2M | -417.31%-72.83M | 162.60%36.64M | 118.41%12.74M | -180.78%-116.98M | -117.91%-12.22M | 140.85%22.95M | -137.49%-58.53M | -196.61%-69.2M |
End cash Position | 24.26%157.51M | 24.26%157.51M | -25.66%103.31M | 51.82%176.14M | -20.08%139.5M | -47.99%126.76M | -47.99%126.76M | -20.82%138.98M | -49.93%116.02M | 130.87%174.55M |
Free cash flow | -45.63%261.96M | -76.89%25.91M | -19.83%115.34M | -111.93%-8.62M | -15.79%129.32M | 181.55%481.77M | -26.82%112.11M | 150.68%143.86M | 286.34%72.23M | 364.06%153.58M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |